chrisvoncsefalvay/vaers-outcomes huggingface dataset:
bruised the side of his underarm okay; that night, in bed he experienced severe vertigo; light headedness; dizziness; This is a spontaneous report from contactable consumer. This consumer reported for a 66-year-old male (Husband) patient.   A 66-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6207, Expiration Date: 31Jul2021) via an unspecified route of administration on 13Mar2021 at 10:13 (at the age of 66-years-old) as dose number unknown, single for covid-19 immunization. Patient medical history included acid reflux disease from an unknown date and unknown if ongoing. Concomitant medications included omeprazole; sertraline and ascorbic acid, tocopherol (VITAMIN C AND E). Reporter stated that well, she was calling on behalf of her husband, who received the Pfizer vaccine on 13Mar2021, 10:13 in the morning, that night, in bed patient experienced severe vertigo, when he rolled over he thought the bed was going to flip over, patient got up the next morning and did not say anything to her, she did not know what happened patient went to sit down on the toilet, it happened again and he fell into the vanity and bruised the side of his underarm okay (14Mar2021), he has had on and off vertigo, light headedness (Mar2021), dizziness (Mar2021), since he got the shot, she was trying to find out, if this was going to go away, he had doctor's appointment on Friday which she was not sure what they are going to tell them if this was the result of shot or if there was anything he can do, but they both felt that this was the result of the shot within 24 hours patient had been experiencing that, she was, from what she could see online on message boards there were many people that have experiencing that. Reporter stated, that would be, it would be going to bed on 13Mar2021 and waking up in the middle of the night and experiencing that, so within 24 hours that's why she can't help but thought that these were related and then he had periodic episode of these for the last week since he had it. Reporter stated, it has been 8 days now, she was trying to report a problem that healthy man has experienced in 24 hours of getting the shot and now the problem was, she does not know whether or not when this was going to go away patient experienced dizziness he can't drive, he has like vertigo situation. Reporter stated that the events had improved somewhat and want to know was this common or does it go away in a week. It was stated that other vaccine people were fine within day or two, now they are on day 8 and this was reporter concern why the events had not gone, and patient felt little off since he had the vaccine. Therapeutic measures were taken as a result of the event vertigo and reporter stated all he has taken was over the counter, Meclizine it was motion, it was over the counter, no prescription, since patient could not get the doctor appointment until Friday. Outcome of all the events was recovering.  No follow-up attempts are Possible. No further Information is expected.
Patient stated that after 1 hour later of getting the SHINGRIX vaccine, she developed facial flushing, nasal numbness and tingling, mucus and swollen of the nostrils, and the right cleared up a day later, but the left one still swollen. Patient did see her doctor for it but doctor doesn't think it's life-threatening.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 10-NOV-2015 the patient was vaccinated with MMRII (lot # L012479, expiration date 10-APR-2017, dose and route not reported), which was exposed to temperatures outside of the recommended temperature. No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Patient recieved dose of pfizer COVID-19 vaccine and at some point during the week after had a seizure that lasted 10 seconds. Patient is being monitored.
Systemic: felt like she was going to pass out, short term memory loss-Severe, Systemic: Shakiness-Medium, Systemic: Tachycardia-Medium
has not received 2nd dose yet; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (has not received 2nd dose yet) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (has not received 2nd dose yet). On 21-Mar-2021, PRODUCT DOSE OMISSION ISSUE (has not received 2nd dose yet) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Within 4 hours of the vaccine patient reported very painful arm to the point she could not lift shoulder. Throughout the evening she reported Headache, uncontrollable shivering, fatigue, muscle weakness, and nausea. She also has a fever of 100.0 2 hours after 400 mg of ibuprofen.
aprox 2.5 hrs after imunization flat red itching rash back, chest, armes.  Resolved after benidril at home.  no respratory symptoms
This spontaneous report was received from a physician refers to a female patient of unknown age. On an unknown date the patient was vaccinated with dose 1, of GARDASIL (lot #, expiration date and route not reported). On an unknown date the patient experienced all over muscle aches. Creatinine Protein Kinase (CPK) was normal. The patient sought medical attention by contacting the physician. The outcome of all over muscle aches was reported as recovered/resolved on an unknown date. Causality was not reported. Additional information has been requested.
She feels sick; Swollen lymph's; Headache; Sore arm; Sore eyes; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (She feels sick), LYMPHADENOPATHY (Swollen lymph's), HEADACHE (Headache), MYALGIA (Sore arm) and EYE PAIN (Sore eyes) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Jul-2021, the patient experienced LYMPHADENOPATHY (Swollen lymph's), HEADACHE (Headache), MYALGIA (Sore arm) and EYE PAIN (Sore eyes). On an unknown date, the patient experienced MALAISE (She feels sick). At the time of the report, MALAISE (She feels sick), LYMPHADENOPATHY (Swollen lymph's), HEADACHE (Headache), MYALGIA (Sore arm) and EYE PAIN (Sore eyes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported.  No treatment details were provided.
signs and symptoms:itching, dizziness, hives symptoms began at around 1030. treated at clinic fo adverse reaction to anthrax vaccine.
Pain at site of injection, L shoulder, started several hours after injection, worsened by the end of the day to the point that it was difficult to use L arm.   In addition, there were diffuse body aches, chills and fatigue overnight.  Chills resolved by next morning.  Body aches and fatigue still present.
Headache, Myalgia, Arthralgia, Fever & Angina Narrative:
confusion, lethargic, fever, swollen arm, numbness from waist to knee's, purple face, veins in legs hurting, hallucinations
Patients were given shots during excursions; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients were given shots during excursions) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 29-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 ml. On 29-Oct-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients were given shots during excursions). On 29-Oct-2021, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients were given shots during excursions) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant products were not provided.  Treatment medications were not reported.
This spontaneous report as received from a 67 year old male patient, reporting on himself, with asthma. No other medical history or concurrent conditions of the patient were reported. In January 2016 the patient was vaccinated with ZOSTAVAX, subcutaneous. The strength, dose, frequency, lot # and expiration date were not provided. Concomitant therapies included cortisone acetate (manufacturer unknown). In March 2016 the patient developed a blistering rash on both wrists and up both arms (dermatitis bullous). The patient saw his physician and acyclovir was prescribed. The patient stated that after about 10 days the rash appeared to dissipate for few weeks. Recently, in June 2016, the blistering rash had reappeared. At the time of reporting the outcome of blistering rash on both wrists and up both arms (dermatitis bullous) was reported as not recovered. The causality between blistering rash on both wrists and up both arms (dermatitis bullous) and ZOSTAVAX was unknown. Upon internal review the event of blistering rash on both wrists and up both arms (dermatitis bullous) was considered medically significant. Additional information has been requested.
11/2/00, sudden onset of severe vertigo and nausea, lasting 6 hours and lingering for several days. On 11/6/00, sudden onset severe vertigo and nausea, lasting 10 hours and lingering several days. Saw ENT MD on 11/7/00 and was prescribed valium and rest. I had follow-up with MD ENT on 11/17/00. I continue to have frequent periods of mild motion sickness and periods of feeling off balance.
Has not received his second dose; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 69-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 9th July 2021, intramuscularly in unknown arm ).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The case was reported by patient's wife. The age at vaccination was not applicable for this report. The patient received his first dose and had not yet received his second dose, which led to incomplete course of vaccination. The reason for delay was unknown.  The reporter did not consent to follow-up.
little under the weather; A little tired; fever; chills; allergy; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (little under the weather), FATIGUE (A little tired), PYREXIA (fever), CHILLS (chills) and HYPERSENSITIVITY (allergy) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MALAISE (little under the weather), FATIGUE (A little tired), PYREXIA (fever), CHILLS (chills) and HYPERSENSITIVITY (allergy). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. At the time of the report, MALAISE (little under the weather), FATIGUE (A little tired), PYREXIA (fever), CHILLS (chills) and HYPERSENSITIVITY (allergy) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) 2 negative rapid tests and negative (Negative) negative PCR test.         No concomitant medications were reported.    This case was linked to MOD-2021-322232 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 17-Sep-2021: Follow up received, New events and the treatment medication added.
Patient states she felt some fluid build-up start on the evening of the injection at lower part of arm close to her elbow. She states the swelling became worse over the next day and turned red. She scheduled an appointment with her doctor for Wednesday 9/26/18.  He prescribed her Augmentin 875mg BID for 7 days.
Ringing in left ear 3 different times. Roaring vibrating sound in right ear one time. Extreme muscle and joint pain. Flu-like body aches. Slight mental confusion.
NOV97 numbness plantar rt big toe;JAN98 to ball of same foot lt side numbness lt index finger & thumb started;25FEB numbness both legs w/tingling;dx disturbance of sensation & cervical pain;hosp dx post vax autoimmune transverse myelitis;
This spontaneous report as received from two nurses' conversation refers to a 65 years old patient. The patient was vaccinated with PNEUMOVAX 23. Lot #, date and route were unspecified. It was reported that PNEUMOVAX 23 gave the patient reaction of swelling in the arm on 31-AUG-2012. The outcome of swelling in the arm was unknown. The patient sought unspecified medical attention. This is one of several reports received from the same source (MARRS 1209USA004430). Additional information is not expected.
Child c/o itching the next AM. Mom looked at the site and noted redness of approx "slightly larger than a 50 cent piece with swelling noted at that time. Given 10 mg (1 1/2 tsp) Benadryl. By that afternoon the erythema and swelling had progressed down to elbow and was spreading to the underside of the arm. Given 2nd dose of Benadryl. Areas also flat to touch and was swollen with what appeared as one large contiguous hive. By Saturday AM 10/20/07, color fading, Sunday 10/21, no longer hot to touch, could see border on where red rash had been on Monday. Today appears as a bruise of smaller rxn.
Tongue numbness, tingling, and itching began 7-10 minutes after vaccine administration.  Throat itching began several minutes later.  Zyrtec was given by mouth.  Symptoms persisted but did not worsen.  Solumedrol 40 mg IM was given.  Symptoms persisted for several hours but did not progress.  There was no shortness of breath or swelling of lips or tongue.   Of note, first dose resulted in 2in x 2in severely pruritic, bright red area at injection site and itching of both palms and vaccinated arm for over a week.
pt recv flu vax & dx GBS 10days post vax;devel proximal weakness in lower extremities & paresthesias in both hands & feet;unable to arise from a squat & areflexic x/for trace responses @ biceps;Romberg test was positive;
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 36-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 18Oct2021 as dose number unknown, single (Batch/Lot number: unknown) at the age of 35 years, in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Amoxicillen, reaction(s): "known allergies: Amoxicillen", notes: known allergies: Amoxicillen. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Sep2023, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
positive after 1st dose; positive after 1st dose; This is a spontaneous report from Pfizer-sponsored program by a contactable Consumer (patient). A female patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for Covid-19 immunisation. The patient medical history and concomitant medication were not reported. It was reported that patient tested positive after 1st dose of covid vaccine. The patient wanted to know about getting second dose. The outcome of the events was unknown.  Information about batch/lot number has been requested.
RED HIVES ON TORSO THAT RAISED AND COVER THE LEFT SIDE BOTH FRONT AND BACK; LOW TO MODERATE FEVER; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient is not prone to allergies or skin reactions. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. Batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the subject experienced red hives on torso that raised and cover the left side both front and back, and low to moderate fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the low to moderate fever and red hives on torso that raised and cover the left side both front and back was not reported. This report was non-serious.
Information has been received from a 60 year old female consumer referring to herself. There was no concomitant medication, pertinent medical history or drug reactions or allergies. On 07-OCT-2016, the patient received a dose of ZOSTAVAX (dose, lot number and expiration date were unknown) injection subcutaneously. On 11-OCT-2016, the patient began to feel sick, and on 14-OCT-2016, the patient had severe breathing problems and chest pains. The patient went to an unspecified Emergency Room where they found bumps and a rash developing on the left side of her chest, and referred her to her primary physician for further evaluation. On 17-OCT-2016, the patient saw her physician who after seeing the rash and bumps diagnosed her with shingles. The physician prescribed prednisone (unspecified manufacturer) and valacyclovir hydrochloride (unspecified manufacturer). The patient has been using the medications for about 3 days and her symptoms seem to be worsening, and spreading over her entire chest and around to her back. No lab diagnostics was performed. The patient has not scheduled to see her provider again as of yet. Additional information has been requested.
Rash at injection site Rash appeared one week later, was very itchy, with raised bumps like hives, approx. 3-4 inches in diameter In following days rash expanded in area to cover upper arm, 8-10 inches, became more flat, uniformly inflamed, itched and was warm to the touch Rash substantially resolved approx. 10 days later, though some mild itching remains
Initial unsolicited report received from a consumer (self) via other company, Pfizer (Reference number-2016497647) on 09 November 2016. This case involves an adult patient (Age and sex was not reported) who was vaccinated with INFLUENZA VACCINE (Flu shot) (lot number, expiration date, dose, dose in series, route of administration and site of administration were not reported) on an unspecified day. Patient's medical history and concomitant medications were not reported. On an unknown day, unspecified timeframe following the vaccination, the patient had developed little redness over arm. Laboratory investigations and corrective treatment were not reported. The outcome of event was not reported. List of documents held by sender: none.
Fever, swollen lymph nodes- axcillary, migraine.  treated with prednisone, hydrocortisone, cimetidine
severe reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (severe reaction) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION COMPLICATION (severe reaction). At the time of the report, VACCINATION COMPLICATION (severe reaction) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator No treatment medications provided by the reporter.
soreness at injection site; headache; This is a spontaneous report received from a contactable consumer. The reporter is the patient.  A 43-year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administered in the left arm, administration date 25Mar2021 15:45 (Lot number: EK5730) at the age of 43 years as dose 2, single for COVID-19 immunisation. Relevant medical history included: "known allergies: penicillins" (unspecified if ongoing); "known allergies: cephalosporins" (unspecified if ongoing); "known allergies: sulfa" (unspecified if ongoing). The patient took concomitant medications. Past drug history included: Mastisol, reaction: "known allergies"; Bactrim, reaction: "known allergies". Vaccination history included: BNT162B2 (dose 1, administered in the left arm, Lot number: EJ1685), administration date: 04Mar2021 15:45, when the patient was 43 years old, for COVID-19 immunisation. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 25Mar2021 21:00, outcome "recovering", described as "soreness at injection site"; HEADACHE (non-serious) with onset 25Mar2021 21:00, outcome "recovering", described as "headache". Therapeutic measures were not taken as a result of vaccination site pain, headache.  Additional information: Other medications the patient received within two weeks of vaccination included daily multivitamin. The patient also received a third dose of BNT162B2 (Lot number: FJ8762), administered in the right arm on 09Dec2021 13:00 for COVID-19 immunisation.  Follow-up attempts are completed. No further information is expected.
My daughter started running a temp of 104 degrees the 7th day after receiving the mmr and chicken pox vaccine. She was hospitalized on day 9. The temp lasted until the evening of day 10. She had all kinds of lab work done and the only thing found were trace amounts of blood in her urine.
Information has been received from a health professional concerning an 11 year old male who on 03-DEC-2007 was vaccinated with varicella virus vaccine live (Oka/Merck) (lot# 1352U). Concomitant therapy included DTaP-IPV and meningococcal vaccine (unspecified). Subsequently, the patient fainted after the vaccination. Prior to the vaccination the patient appeared to be nervous. Unknown medical attention was sought. The patient's outcome is unknown. No product quality complaint was involved. This is one of the multiple reports from the same source. Further information has been requested.
mild fatigue, mild fever, chills, aches, on just the evening of 1/20/21, the day after shot